In response to injury of the central nervous system, astrocytes become reactive and express high levels of the intermediate filament (IF) proteins glial fibrillary acidic protein (GFAP), vimentin, and nestin. We have shown that astrocytes in mice deficient for both GFAP and vimentin (GFAP−/−vim−/−) cannot form IFs even when nestin is expressed and are thus devoid of IFs in their reactive state. Here, we have studied the reaction to injury in the central nervous system in GFAP−/−, vimentin−/−, or GFAP−/−vim−/− mice. Glial scar formation appeared normal after spinal cord or brain lesions in GFAP−/− or vimentin−/− mice, but was impaired in GFAP−/−vim−/− mice that developed less dense scars frequently accompanied by bleeding. These results show that GFAP and vimentin are required for proper glial scar formation in the injured central nervous system and that some degree of functional overlap exists between these IF proteins.
Skip Nav Destination
Article navigation
3 May 1999
Article|
May 03 1999
Abnormal Reaction to Central Nervous System Injury in Mice Lacking Glial Fibrillary Acidic Protein and Vimentin
Milos Pekny,
Milos Pekny
*Department of Medical Biochemistry and ‡Department of Anatomy and Cell Biology, Gothenburg University, SE-405 30 Gothenburg, Sweden; and §Department of Cell and Molecular Biology, Medical Nobel Institute, ‖ Department of Neuroscience, Karolinska Institute and ¶Ludwig Institute for Cancer Research, Stockholm Branch, SE-17177 Stockholm, Sweden
Search for other works by this author on:
Clas B. Johansson,
Clas B. Johansson
*Department of Medical Biochemistry and ‡Department of Anatomy and Cell Biology, Gothenburg University, SE-405 30 Gothenburg, Sweden; and §Department of Cell and Molecular Biology, Medical Nobel Institute, ‖ Department of Neuroscience, Karolinska Institute and ¶Ludwig Institute for Cancer Research, Stockholm Branch, SE-17177 Stockholm, Sweden
Search for other works by this author on:
Camilla Eliasson,
Camilla Eliasson
*Department of Medical Biochemistry and ‡Department of Anatomy and Cell Biology, Gothenburg University, SE-405 30 Gothenburg, Sweden; and §Department of Cell and Molecular Biology, Medical Nobel Institute, ‖ Department of Neuroscience, Karolinska Institute and ¶Ludwig Institute for Cancer Research, Stockholm Branch, SE-17177 Stockholm, Sweden
Search for other works by this author on:
Josefina Stakeberg,
Josefina Stakeberg
*Department of Medical Biochemistry and ‡Department of Anatomy and Cell Biology, Gothenburg University, SE-405 30 Gothenburg, Sweden; and §Department of Cell and Molecular Biology, Medical Nobel Institute, ‖ Department of Neuroscience, Karolinska Institute and ¶Ludwig Institute for Cancer Research, Stockholm Branch, SE-17177 Stockholm, Sweden
Search for other works by this author on:
Åsa Wallén,
Åsa Wallén
*Department of Medical Biochemistry and ‡Department of Anatomy and Cell Biology, Gothenburg University, SE-405 30 Gothenburg, Sweden; and §Department of Cell and Molecular Biology, Medical Nobel Institute, ‖ Department of Neuroscience, Karolinska Institute and ¶Ludwig Institute for Cancer Research, Stockholm Branch, SE-17177 Stockholm, Sweden
Search for other works by this author on:
Thomas Perlmann,
Thomas Perlmann
*Department of Medical Biochemistry and ‡Department of Anatomy and Cell Biology, Gothenburg University, SE-405 30 Gothenburg, Sweden; and §Department of Cell and Molecular Biology, Medical Nobel Institute, ‖ Department of Neuroscience, Karolinska Institute and ¶Ludwig Institute for Cancer Research, Stockholm Branch, SE-17177 Stockholm, Sweden
Search for other works by this author on:
Urban Lendahl,
Urban Lendahl
*Department of Medical Biochemistry and ‡Department of Anatomy and Cell Biology, Gothenburg University, SE-405 30 Gothenburg, Sweden; and §Department of Cell and Molecular Biology, Medical Nobel Institute, ‖ Department of Neuroscience, Karolinska Institute and ¶Ludwig Institute for Cancer Research, Stockholm Branch, SE-17177 Stockholm, Sweden
Search for other works by this author on:
Christer Betsholtz,
Christer Betsholtz
*Department of Medical Biochemistry and ‡Department of Anatomy and Cell Biology, Gothenburg University, SE-405 30 Gothenburg, Sweden; and §Department of Cell and Molecular Biology, Medical Nobel Institute, ‖ Department of Neuroscience, Karolinska Institute and ¶Ludwig Institute for Cancer Research, Stockholm Branch, SE-17177 Stockholm, Sweden
Search for other works by this author on:
Claes-Henric Berthold,
Claes-Henric Berthold
*Department of Medical Biochemistry and ‡Department of Anatomy and Cell Biology, Gothenburg University, SE-405 30 Gothenburg, Sweden; and §Department of Cell and Molecular Biology, Medical Nobel Institute, ‖ Department of Neuroscience, Karolinska Institute and ¶Ludwig Institute for Cancer Research, Stockholm Branch, SE-17177 Stockholm, Sweden
Search for other works by this author on:
Jonas Frisén
Jonas Frisén
*Department of Medical Biochemistry and ‡Department of Anatomy and Cell Biology, Gothenburg University, SE-405 30 Gothenburg, Sweden; and §Department of Cell and Molecular Biology, Medical Nobel Institute, ‖ Department of Neuroscience, Karolinska Institute and ¶Ludwig Institute for Cancer Research, Stockholm Branch, SE-17177 Stockholm, Sweden
Search for other works by this author on:
Milos Pekny
*Department of Medical Biochemistry and ‡Department of Anatomy and Cell Biology, Gothenburg University, SE-405 30 Gothenburg, Sweden; and §Department of Cell and Molecular Biology, Medical Nobel Institute, ‖ Department of Neuroscience, Karolinska Institute and ¶Ludwig Institute for Cancer Research, Stockholm Branch, SE-17177 Stockholm, Sweden
Clas B. Johansson
*Department of Medical Biochemistry and ‡Department of Anatomy and Cell Biology, Gothenburg University, SE-405 30 Gothenburg, Sweden; and §Department of Cell and Molecular Biology, Medical Nobel Institute, ‖ Department of Neuroscience, Karolinska Institute and ¶Ludwig Institute for Cancer Research, Stockholm Branch, SE-17177 Stockholm, Sweden
Camilla Eliasson
*Department of Medical Biochemistry and ‡Department of Anatomy and Cell Biology, Gothenburg University, SE-405 30 Gothenburg, Sweden; and §Department of Cell and Molecular Biology, Medical Nobel Institute, ‖ Department of Neuroscience, Karolinska Institute and ¶Ludwig Institute for Cancer Research, Stockholm Branch, SE-17177 Stockholm, Sweden
Josefina Stakeberg
*Department of Medical Biochemistry and ‡Department of Anatomy and Cell Biology, Gothenburg University, SE-405 30 Gothenburg, Sweden; and §Department of Cell and Molecular Biology, Medical Nobel Institute, ‖ Department of Neuroscience, Karolinska Institute and ¶Ludwig Institute for Cancer Research, Stockholm Branch, SE-17177 Stockholm, Sweden
Åsa Wallén
*Department of Medical Biochemistry and ‡Department of Anatomy and Cell Biology, Gothenburg University, SE-405 30 Gothenburg, Sweden; and §Department of Cell and Molecular Biology, Medical Nobel Institute, ‖ Department of Neuroscience, Karolinska Institute and ¶Ludwig Institute for Cancer Research, Stockholm Branch, SE-17177 Stockholm, Sweden
Thomas Perlmann
*Department of Medical Biochemistry and ‡Department of Anatomy and Cell Biology, Gothenburg University, SE-405 30 Gothenburg, Sweden; and §Department of Cell and Molecular Biology, Medical Nobel Institute, ‖ Department of Neuroscience, Karolinska Institute and ¶Ludwig Institute for Cancer Research, Stockholm Branch, SE-17177 Stockholm, Sweden
Urban Lendahl
*Department of Medical Biochemistry and ‡Department of Anatomy and Cell Biology, Gothenburg University, SE-405 30 Gothenburg, Sweden; and §Department of Cell and Molecular Biology, Medical Nobel Institute, ‖ Department of Neuroscience, Karolinska Institute and ¶Ludwig Institute for Cancer Research, Stockholm Branch, SE-17177 Stockholm, Sweden
Christer Betsholtz
*Department of Medical Biochemistry and ‡Department of Anatomy and Cell Biology, Gothenburg University, SE-405 30 Gothenburg, Sweden; and §Department of Cell and Molecular Biology, Medical Nobel Institute, ‖ Department of Neuroscience, Karolinska Institute and ¶Ludwig Institute for Cancer Research, Stockholm Branch, SE-17177 Stockholm, Sweden
Claes-Henric Berthold
*Department of Medical Biochemistry and ‡Department of Anatomy and Cell Biology, Gothenburg University, SE-405 30 Gothenburg, Sweden; and §Department of Cell and Molecular Biology, Medical Nobel Institute, ‖ Department of Neuroscience, Karolinska Institute and ¶Ludwig Institute for Cancer Research, Stockholm Branch, SE-17177 Stockholm, Sweden
Jonas Frisén
*Department of Medical Biochemistry and ‡Department of Anatomy and Cell Biology, Gothenburg University, SE-405 30 Gothenburg, Sweden; and §Department of Cell and Molecular Biology, Medical Nobel Institute, ‖ Department of Neuroscience, Karolinska Institute and ¶Ludwig Institute for Cancer Research, Stockholm Branch, SE-17177 Stockholm, Sweden
Address correspondence to Dr. Milos Pekny, Department of Medical Biochemistry, University of Gothenburg, Box 440, SE-405 30 Gothenburg, Sweden. Tel.: 46 31 7733269. Fax: 46 31 416108. E-mail: milos.pekny @medkem.gu.se
The first three authors contributed equally to this study.
Received:
April 17 1998
Revision Received:
March 17 1999
Online ISSN: 1540-8140
Print ISSN: 0021-9525
1999
J Cell Biol (1999) 145 (3): 503–514.
Article history
Received:
April 17 1998
Revision Received:
March 17 1999
Citation
Milos Pekny, Clas B. Johansson, Camilla Eliasson, Josefina Stakeberg, Åsa Wallén, Thomas Perlmann, Urban Lendahl, Christer Betsholtz, Claes-Henric Berthold, Jonas Frisén; Abnormal Reaction to Central Nervous System Injury in Mice Lacking Glial Fibrillary Acidic Protein and Vimentin . J Cell Biol 3 May 1999; 145 (3): 503–514. doi: https://doi.org/10.1083/jcb.145.3.503
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement
Advertisement